Shenyang Xingqi Pharmaceutical Co Ltd (300573) — Capital Reinvestment Ratio

Latest as of September 2025: 0.16x

Shenyang Xingqi Pharmaceutical Co Ltd (300573) has a Capital Reinvestment Ratio of 0.16x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥268.97 Million) in capital expenditures (CN¥43.05 Million). See 300573 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.16x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥268.97 Million
CNY

Capital Expenditures

CN¥43.05 Million
CNY

Data as of

Sep 2025
Most recent filing

Shenyang Xingqi Pharmaceutical Co Ltd Capital Reinvestment Ratio (2011–2024)

This chart tracks Shenyang Xingqi Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 14 annual periods.

Annual Capital Reinvestment Ratio for Shenyang Xingqi Pharmaceutical Co Ltd (2011–2024)

Year-by-year Capital Reinvestment Ratio for Shenyang Xingqi Pharmaceutical Co Ltd from 2011 to 2024. For live market cap and broader valuation context, see 300573 company net worth.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2024 0.48x CN¥416.98 Million CN¥198.71 Million ▼ -42.2%
2023 0.82x CN¥317.57 Million CN¥261.96 Million ▼ -21.1%
2022 1.05x CN¥286.26 Million CN¥299.23 Million ▲ +237.5%
2021 0.31x CN¥306.96 Million CN¥95.06 Million ▼ -65.0%
2020 0.89x CN¥122.16 Million CN¥108.15 Million ▼ -6.3%
2019 0.94x CN¥74.08 Million CN¥69.98 Million ▼ -8.2%
2018 1.03x CN¥44.01 Million CN¥45.29 Million ▲ +14.9%
2017 0.90x CN¥32.70 Million CN¥29.29 Million ▲ +595.8%
2016 0.13x CN¥28.12 Million CN¥3.62 Million ▼ -41.1%
2015 0.22x CN¥21.43 Million CN¥4.69 Million ▼ -96.5%
2014 6.29x CN¥13.00 Million CN¥81.79 Million ▼ -60.3%
2013 15.83x CN¥8.40 Million CN¥132.98 Million ▲ +543.5%
2012 2.46x CN¥41.96 Million CN¥103.25 Million ▲ +43.6%
2011 1.71x CN¥24.54 Million CN¥42.06 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow